ArticleBMC genomics2026
Identification and genomic insights into a plant probiotic Bacillus subtilis strain CF1 isolated from Protaetia brevitarsis frass.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPlant probiotic bacteria offer a sustainable strategy for enhancing crop health and productivity. Insect frass has emerged as a unique niche for isolating beneficial microorganisms with novel traits. In this study, we isolated a bacterial strain CF1 from the frass of Protaetia brevitarsis and characterized its biocontrol and plant growth‑promoting potential against Fusarium crown rot of wheat.
resultsBased on whole‑genome analysis, strain CF1 was identified as Bacillus subtilis. CF1 exhibited strong antagonistic activity against Fusarium graminearum and F. asiaticum, with inhibition rates of 34.67% and 33.95%, respectively. Its cell‑free filtrate showed dose‑dependent antifungal activity, reaching 43.70% inhibition against F. graminearum at a 5‑fold dilution. Phenotypic characterization confirmed its ability to produce IAA equivalents, siderophores, and solubilized phosphate. In pot experiments, CF1 effectively suppressed Fusarium crown rot, achieving a biocontrol efficacy of 43.47%, comparable to that of the well‑characterized strain B. velezensis SQR9 (44.07%). The inoculation of CF1 also promoted wheat growth, increasing plant height and plant biomass. Whole-genome sequencing revealed a 4.11 Mb genome encoding 4,277 genes, with 11 biosynthetic gene clusters for secondary metabolites, including bacillaene, fengycin, bacillibactin, surfactin, bacilysin, subtilomycin, subtilosin A, and pulcherriminic acid, along with three biosynthetic gene clusters of unknown function, suggesting potentially unique bioactivities. Genome mining further uncovered numerous genes associated with plant growth promotion, rhizosphere colonization, stress resistance, and volatile organic compound production.
conclusionsB. subtilis CF1 is a promising microbial agent that combines strong antifungal activity, plant growth‑promoting traits, and a diverse set of genetic features that may confer unique properties, warranting further field validation for sustainable wheat production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.